Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.

The American journal of pathology - 1 May 2009

Kuo Kuan-Ting, Mao Tsui-Lien, Jones Siân, Veras Emanuela, Ayhan Ayse, Wang Tian-Li, Glas Ruth, Slamon Dennis, Velculescu Victor E, Kuman Robert J, Shih Ie-Ming

Abstract excerpt

Ovarian clear cell carcinoma (CCC) is one of the most malignant types of ovarian carcinomas, particularly at advanced stages. Unlike the more common type of ovarian cancer, high-grade serous carcinoma, ovarian CCC is often resistant to platinum-based chemotherapy, and therefore an effective treat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Adenocarcinoma, Mucinous
Share to Carcinoma, Endometrioid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Cystadenocarcinoma, Serous

Share to Immunoenzyme Techniques

Share to Ovarian Neoplasms

Share to Phosphatidylinositol 3-Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 19349352
DOI: 10.2353/ajpath.2009.081000
PMCID: PMC2671248

Genes

BRAF
CTNNB1
KRAS
PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19349352-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.PMID 19349352Read ↗

Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.Semantic proximity Read ↗

Clinical analysis and literature review of a case of ovarian clear cell carcinoma with PIK3CA gene mutation: A case report.Semantic proximity Read ↗

Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.Semantic proximity Read ↗

Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.Semantic proximity Read ↗

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.Semantic proximity Read ↗

Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing.Semantic proximity Read ↗

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.Semantic proximity Read ↗

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.Semantic proximity Read ↗

DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.Semantic proximity Read ↗

Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms.Semantic proximity Read ↗

Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients.Semantic proximity Read ↗

Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic targetSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.